Research and Regulatory Status Approved Use (Native IGF-1): The native recombinant human IGF-1 (Mecasermin) is FDA-approved for growth failure in children with severe IGF-1 deficiency
As a result, the benefits of peptide therapy may be less than expected
Carbon dot therapeutic platforms: Administration, distribution, metabolism, excretion, toxicity, and therapeutic potential
Similarly, next-generation p38MAPK inhibitors UR-13756 and BIRB 796 inhibited IL-6 expression in human senescent fibroblasts, demonstrating their effectiveness in reducing SASP-related effects (93)
At Pulse & Remedy Concierge Medicine, we offer a personalized healthcare experience designed to meet your unique needs
Anti-Inflammatory and Antioxidant Activity GHK-Cu has been shown to reduce levels of pro-inflammatory signaling molecules in tissue [4]